Log in

NASDAQ:DOX - Amdocs Stock Price, Forecast & News

$63.75
-2.44 (-3.69 %)
(As of 02/28/2020 04:00 PM ET)
Today's Range
$62.69
Now: $63.75
$65.83
50-Day Range
$63.75
MA: $72.97
$76.07
52-Week Range
$52.90
Now: $63.75
$77.29
Volume1.56 million shs
Average Volume875,410 shs
Market Capitalization$8.59 billion
P/E Ratio17.66
Dividend Yield1.72%
Beta0.43
Amdocs Limited, through its subsidiaries, provides software and services to the communications, pay TV, entertainment, and media industry service providers worldwide. The company offers amdocsONE a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support, as well as consumer experience and monetization, media and digital, enterprise and connected society, service-driven network, and services and agile operation solutions. Read More…

Industry, Sector and Symbol

Industry Custom computer programming services
Sub-IndustryIT Consulting & Other Services
SectorComputer and Technology
Current SymbolNASDAQ:DOX
CUSIPG0260210
Phone1 314 212 7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.09 billion
Cash Flow$5.49 per share
Book Value$26.58 per share

Profitability

Net Income$479.45 million

Miscellaneous

Employees24,516
Market Cap$8.59 billion
Next Earnings Date5/12/2020 (Estimated)
OptionableOptionable

Receive DOX News and Ratings via Email

Sign-up to receive the latest news and ratings for DOX and its competitors with MarketBeat's FREE daily newsletter.


Amdocs (NASDAQ:DOX) Frequently Asked Questions

What is Amdocs' stock symbol?

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

How often does Amdocs pay dividends? What is the dividend yield for Amdocs?

Amdocs announced a quarterly dividend on Tuesday, February 4th. Investors of record on Tuesday, March 31st will be given a dividend of $0.327 per share on Friday, April 24th. This represents a $1.31 dividend on an annualized basis and a yield of 2.05%. The ex-dividend date of this dividend is Monday, March 30th. This is a boost from Amdocs's previous quarterly dividend of $0.29. View Amdocs' Dividend History.

How were Amdocs' earnings last quarter?

Amdocs Limited (NASDAQ:DOX) posted its quarterly earnings results on Tuesday, February, 4th. The technology company reported $1.06 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.05 by $0.01. The technology company earned $1.04 billion during the quarter, compared to analysts' expectations of $1.03 billion. Amdocs had a net margin of 11.99% and a return on equity of 16.13%. The business's revenue for the quarter was up 3.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.98 EPS. View Amdocs' Earnings History.

When is Amdocs' next earnings date?

Amdocs is scheduled to release their next quarterly earnings announcement on Tuesday, May 12th 2020. View Earnings Estimates for Amdocs.

What guidance has Amdocs issued on next quarter's earnings?

Amdocs issued an update on its FY20 earnings guidance on Tuesday, February, 4th. The company provided EPS guidance of $4.44-4.61 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.52. The company issued revenue guidance of $4.19-4.31 billion, compared to the consensus revenue estimate of $4.22 billion.

What price target have analysts set for DOX?

5 Wall Street analysts have issued twelve-month price targets for Amdocs' shares. Their forecasts range from $72.00 to $85.00. On average, they expect Amdocs' share price to reach $77.80 in the next year. This suggests a possible upside of 22.0% from the stock's current price. View Analyst Price Targets for Amdocs.

What is the consensus analysts' recommendation for Amdocs?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Amdocs.

Has Amdocs been receiving favorable news coverage?

Headlines about DOX stock have trended very negative this week, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Amdocs earned a news impact score of -3.4 on InfoTrie's scale. They also assigned media headlines about the technology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Amdocs.

Are investors shorting Amdocs?

Amdocs saw a increase in short interest in the month of February. As of February 14th, there was short interest totalling 3,690,000 shares, an increase of 9.8% from the January 30th total of 3,360,000 shares. Based on an average daily trading volume, of 776,500 shares, the days-to-cover ratio is currently 4.8 days. Approximately 2.7% of the company's shares are sold short. View Amdocs' Current Options Chain.

Who are some of Amdocs' key competitors?

What other stocks do shareholders of Amdocs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include AbbVie (ABBV), Home Depot (HD), AT&T (T), QUALCOMM (QCOM), Enterprise Products Partners (EPD), Activision Blizzard (ATVI), Comcast (CMCSA), Intel (INTC), Boeing (BA) and Caterpillar (CAT).

Who are Amdocs' key executives?

Amdocs' management team includes the folowing people:
  • Mr. Joshua Sheffer, Pres & CEO (Age 59)
  • Ms. Tamar Rapaport-Dagim, CFO & COO (Age 48)
  • Mr. Matthew E. Smith, Sec. & Head of Investor Relations (Age 47)
  • Mr. Gary Miles, Chief Marketing Officer
  • Darcy Antonellis, Head of Amdocs Media

Who are Amdocs' major shareholders?

Amdocs' stock is owned by many different of institutional and retail investors. Top institutional shareholders include FMR LLC (11.85%), Janus Henderson Group PLC (5.60%), Massachusetts Financial Services Co. MA (3.11%), LSV Asset Management (2.56%), Beutel Goodman & Co Ltd. (2.14%) and AQR Capital Management LLC (2.00%).

Which institutional investors are selling Amdocs stock?

DOX stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Echo Street Capital Management LLC, Alliancebernstein L.P., Barclays PLC, Goldman Sachs Group Inc., Janus Henderson Group PLC, PGGM Investments and Eaton Vance Management.

Which institutional investors are buying Amdocs stock?

DOX stock was acquired by a variety of institutional investors in the last quarter, including Bessemer Group Inc., Schroder Investment Management Group, Acadian Asset Management LLC, AJO LP, Stifel Financial Corp, Anchor Capital Advisors LLC, Citigroup Inc. and Charles Schwab Investment Management Inc..

How do I buy shares of Amdocs?

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Amdocs' stock price today?

One share of DOX stock can currently be purchased for approximately $63.75.

How big of a company is Amdocs?

Amdocs has a market capitalization of $8.59 billion and generates $4.09 billion in revenue each year. The technology company earns $479.45 million in net income (profit) each year or $4.07 on an earnings per share basis. Amdocs employs 24,516 workers across the globe.View Additional Information About Amdocs.

What is Amdocs' official website?

The official website for Amdocs is http://www.amdocs.com/.

How can I contact Amdocs?

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]


MarketBeat Community Rating for Amdocs (NASDAQ DOX)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  602 (Vote Outperform)
Underperform Votes:  450 (Vote Underperform)
Total Votes:  1,052
MarketBeat's community ratings are surveys of what our community members think about Amdocs and other stocks. Vote "Outperform" if you believe DOX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DOX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel